105 related articles for article (PubMed ID: 3602697)
1. [Antithrombin III levels in patients with acute thromboembolism during treatment with heparin].
Barja P; Araya MV; Hassi M
Rev Med Chil; 1986 Dec; 114(12):1160-3. PubMed ID: 3602697
[No Abstract] [Full Text] [Related]
2. [Plasma antithrombin III activity in patients with pulmonary thromboembolism].
Vertun B; Filipecki S; Szczepański M; Wawrzyńska L; Rózycka J
Pol Tyg Lek; 1992 Aug 18-31; 47(34-35):726-9. PubMed ID: 1488357
[TBL] [Abstract][Full Text] [Related]
3. [Prevention of perioperative thromboembolism and antithrombin III levels in patients who are to undergo major gynecologic operations].
Viceić M; Janković D; Bernat T; Vecek N; Ljubojević N
Lijec Vjesn; 1988 Nov; 110(11):359-60. PubMed ID: 3231001
[No Abstract] [Full Text] [Related]
4. [Assay of plasma heparin and heparin-antithrombin III complex--studies in normal volunteers and thromboembolic patients].
Oguma Y; Hasegawa H; Nagata H; Kawakami Y
Rinsho Ketsueki; 1986 May; 27(5):723-9. PubMed ID: 3747167
[No Abstract] [Full Text] [Related]
5. Treatment of venous thromboembolism in patients with congenital deficiency of antithrombin III.
Schulman S; Tengborn L
Thromb Haemost; 1992 Dec; 68(6):634-6. PubMed ID: 1287876
[TBL] [Abstract][Full Text] [Related]
6. [Plasma and urinary antithrombin III in the nephrotic syndrome in adults].
Antelin CH; Gouault-Heilmann M; Levent M; Bernard D; Ruszniewski P; Lagrue G
Ann Med Interne (Paris); 1983; 134(8):713-6. PubMed ID: 6666909
[TBL] [Abstract][Full Text] [Related]
7. [A study of antithrombin systems during heparin therapy].
Boneu B; Immaculato F; Sie P; Caranobe C; Chamontin B; Guittard J
Nouv Presse Med; 1982 Oct; 11(41):3043-6. PubMed ID: 6183640
[TBL] [Abstract][Full Text] [Related]
8. A randomized trial comparing activated thromboplastin time with heparin assay in patients with acute venous thromboembolism requiring large daily doses of heparin.
Levine MN; Hirsh J; Gent M; Turpie AG; Cruickshank M; Weitz J; Anderson D; Johnson M
Arch Intern Med; 1994 Jan; 154(1):49-56. PubMed ID: 8267489
[TBL] [Abstract][Full Text] [Related]
9. Antithrombin III in patients with acute deep vein thrombosis during heparin treatment (subcutaneous and intravenous) and during and after treatment with oral coumarins.
Andersson G; Fagrell B; Holmgren K; Johnsson H; Ljungberg B; Wilhelmsson S
Thromb Res; 1984 May; 34(4):333-40. PubMed ID: 6740566
[TBL] [Abstract][Full Text] [Related]
10. [Antithrombin III control in patients with long-term anticoagulant therapy].
Hönig JF; Merten HA; Korth O; Halling F; Köstering H
Dtsch Z Mund Kiefer Gesichtschir; 1991; 15(5):330-3. PubMed ID: 1840095
[TBL] [Abstract][Full Text] [Related]
11. Benefit/risk profile of high-dose antithrombin in patients with severe sepsis treated with and without concomitant heparin.
Hoffmann JN; Wiedermann CJ; Juers M; Ostermann H; Kienast J; Briegel J; Strauss R; Warren BL; Opal SM;
Thromb Haemost; 2006 May; 95(5):850-6. PubMed ID: 16676077
[TBL] [Abstract][Full Text] [Related]
12. [Assessment of the risk of postpartum thromboembolism by measuring antithrombin III levels. A false hope].
Massignon D; Clerc-Renaud P; Desenfant H; Coeur P; Dumont M
J Gynecol Obstet Biol Reprod (Paris); 1986; 15(2):171-2. PubMed ID: 3722743
[TBL] [Abstract][Full Text] [Related]
13. [Antithrombin III in patients with acute myocardial infarct in relation to fibrinolytic therapy].
Soska V; Lupínek Z
Vnitr Lek; 1987 Mar; 33(3):230-4. PubMed ID: 3660676
[No Abstract] [Full Text] [Related]
14. Purification and characterization of hereditary abnormal antithrombin III with impaired thrombin binding.
Jørgensen M; Petersen LC; Thorsen S
J Lab Clin Med; 1984 Aug; 104(2):245-56. PubMed ID: 6747440
[TBL] [Abstract][Full Text] [Related]
15. Vitamin K dependent clotting factors and their inhibitor--with special reference to prothrombin and antithrombin III.
Gonmori H; Tsukada H; Takada M; Tanaka H; Kobayashi N; Maekawa T
Nihon Ketsueki Gakkai Zasshi; 1981 Dec; 44(7):1466-78. PubMed ID: 7342649
[No Abstract] [Full Text] [Related]
16. Comparison of subcutaneous unfractionated heparin with a low molecular weight heparin (Fragmin) in patients with venous thromboembolism and contraindications to coumarin.
Monreal M; Lafoz E; Olive A; del Rio L; Vedia C
Thromb Haemost; 1994 Jan; 71(1):7-11. PubMed ID: 8165649
[TBL] [Abstract][Full Text] [Related]
17. Low dose heparin in elective abdominal surgery. Correlation between concentrations of heparin, antithrombin III and antiplasmin in patients with and without DVT.
Kruse-Blinkenberg HO; Gormsen J; Jensen J; Thomsen F; Wille-Jørgensen P
Acta Chir Scand; 1980; 146(6):383-90. PubMed ID: 7008476
[No Abstract] [Full Text] [Related]
18. [Thrombo-embolic disease as a complication of nephrotic syndrome in children].
Jarmoliński T; Zachwieja J; Bortkiewicz E; Stachowski J; Maciejewski J
Pediatr Pol; 1996 May; 71(5):437-41. PubMed ID: 8710427
[TBL] [Abstract][Full Text] [Related]
19. Antithrombin Nagasaki (Ser 116 to Pro): a rare antithrombin variant with abnormal heparin binding presenting during pregnancy.
O'Ddonnell JS; Hinkson L; McCarthy A; Manning R; Khan A; Laffan MA
Blood Coagul Fibrinolysis; 2006 Apr; 17(3):217-20. PubMed ID: 16575261
[TBL] [Abstract][Full Text] [Related]
20. Randomized comparison of low molecular weight heparin and coumarin derivatives on the survival of patients with cancer and venous thromboembolism.
Lee AY; Rickles FR; Julian JA; Gent M; Baker RI; Bowden C; Kakkar AK; Prins M; Levine MN
J Clin Oncol; 2005 Apr; 23(10):2123-9. PubMed ID: 15699480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
